Komel V. Grover is an experienced strategic development leader in the biopharmaceutical and biotechnology industries. She has an established record of success in creating strategic value by achieving growth in thought leadership, leveraging medical education, engaging in collaborative research, and maximizing the dissemination of pivotal scientific communications. She is currently Vice President of Strategic Initiatives for a private dermatology and manufacturing company with a commanding leadership position in the sunscreen market.
Komel has over 15 years of industry experience, including corporate finance, strategic/business planning, and medical affairs responsibilities in neurology, immunology, cardiology, wound healing and dermatology sectors.
Over this period, her responsibilities have included corporate leadership over clinical research, medical affairs, and medical education that bridged academic centers of excellence and community organizers. Most recently, Komel was the leader of the Strategic Development Platform for Smith & Nephew’s biological drug portfolio where she provided scientific and strategic insights and leadership in support of the Company’s biological assets, the only biological products approved by the FDA in wound care.
Komel also served as a wound care medical education leader. She quickly added value by implementing a corporate-wide advocacy development strategy to engage the top thought leaders in wound care. By collaborating with industry and thought leaders, she was able to grow The Wound Institute® (TWI) digital education platform from 6,000 members in 2007 to over 80,000 in 2016. As part of this effort, she established TWI as the best-in-class platform in wound care, and expanded the scope of the offering to provide first-in-class digital education geared specifically to the patient/caregiver. This patient/caregiver offering has since been recognized by the National Institutes of Health as a MEDLINE/ Pubmed resource and continues to provide education for professionals and patients alike.
Komel is currently the Industry Chairperson for Wound Care Experts: FDA Clinical Endpoints Project. The panel, in association with the two preeminent wound care societies, Wound Healing Society and the Association for the Advancement of Wound Care, is actively working with FDA’s InterCenter Wound Healing Work Group to better define the standards and endpoints of wound care. She has also served her industry with her elected position as AdvaMed’s Wound Healing & Tissue Regeneration Sector Chair (2009-2012). Since 2012, Komel has served as a Board of Director for the Wound Healing Foundation, a non-profit organization dedicated to improving the quality of life for wound healing patients and their families through the support of awareness, research and education.
Komel’s educational background includes medical and cancer biology training at the University of Texas Health Science Center, Houston, as well as MBA coursework at Pepperdine University School of Business and Management and IECS-Robert Schuman Strasbourg Graduate School of Management.